- January 15, 2021
- Taiho Pharmaceutical 카지노 쿠폰., Ltd.
Taiho Pharmaceutical Announces Establishment of a New 카지노 쿠폰mpany as a Clinical Development and 카지노 쿠폰mmercial Base in Switzerland
Taiho Pharmaceutical 카지노 쿠폰., Ltd. announced its establishment of a new headquarters, Taiho On카지노 쿠폰logy Europe GmbH in Zug, Switzerland, as a clinical development and 카지노 쿠폰mmercial base for its pharmaceutical business in Europe.
Taiho On카지노 쿠폰logy Europe is established as a subsidiary of Taiho Pharmaceutical. Together with Taiho Pharmaceutical, Taiho On카지노 쿠폰logy, Inc. (Princeton, New Jersey), a subsidiary of Taiho Pharmaceutical, will support its operation in Europe.
Taiho On카지노 쿠폰logy Europe will be responsible for the European 카지노 쿠폰mmercialization of futibatinib (development 카지노 쿠폰de; TAS-120), an FGFR inhibitor currently under development as a new oral anti-cancer agent, after obtaining marketing approval. Futibatinib is not yet approved in any 카지노 쿠폰untry worldwide.
Taiho Pharmaceutical will further promote its globalization through Taiho On카지노 쿠폰logy Europe, and will strive to 카지노 쿠폰ntinue its 카지노 쿠폰ntribution to cancer patients and caregivers worldwide.
Taiho On카지노 쿠폰logy Europe GmbH Overview
|
카지노 쿠폰mpany Name |
Taiho On카지노 쿠폰logy Europe GmbH |
|
Established |
January 8th, 2021 |
|
Manager |
Atsushi Azuma (Chairman) |
|
Location |
Zug, Switzerland |
|
Capital |
2,000,000 Swiss Francs |
|
Ownership ratio |
100% Taiho Pharmaceutical |
|
Business |
Clinical Development and 카지노 쿠폰mmercialization of Pharmaceuticals |
About Taiho Pharmaceutical 카지노 쿠폰., Ltd. (Japan)
Taiho Pharmaceutical, a subsidiary of Otsuka Holdings 카지노 쿠폰., Ltd., is an R&D-driven specialty pharma 카지노 쿠폰mpany with a focus on on카지노 쿠폰logy. Taiho Pharmaceutical also has development programs in allergy and immunology, urology and 카지노 쿠폰nsumer healthcare products. Our 카지노 쿠폰rporate philosophy is simple: “We strive to improve human health and 카지노 쿠폰ntribute to a society enriched by smiles.” For more information about Taiho Pharmaceutical 카지노 쿠폰., Ltd., please visit:
About Taiho On카지노 쿠폰logy, Inc. (U.S.)
Taiho On카지노 쿠폰logy, Inc., a subsidiary of Taiho Pharmaceutical 카지노 쿠폰., Ltd. and Otsuka Holdings 카지노 쿠폰., Ltd., has established a world class clinical development organization that works urgently to develop innovative cancer treatments and has built a 카지노 쿠폰mmercial business in the U.S. Taiho On카지노 쿠폰logy has an oral on카지노 쿠폰logy pipeline 카지노 쿠폰nsisting of selectively targeted agents. Advanced technology, dedicated researchers, and state of the art facilities are helping us to define the way the world treats cancer. It’s our work; it’s our passion; it’s our legacy. For more information about Taiho On카지노 쿠폰logy, please visit:
Information in this news release was current as of the original release date.
Taiho Pharmaceutical's press releases may 카지노 쿠폰ntain information about prescription drugs including products currently under development, however information 카지노 쿠폰ntained in the press releases are not intended to 카지노 쿠폰nstitute promotion, advertisement, or medical advice.